Related Experiment Video
Updated: Jul 9, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Long-acting inhaled medicines: Present and future
Chengqian Zhang1, Davide D'Angelo2, Francesca Buttini3
1Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
Long-acting inhaled medicines (LAIM) improve patient compliance and treatment effectiveness for respiratory conditions. This review covers advances, technologies, and challenges in developing these crucial long-acting inhaled therapies.
Area of Science:
- Pulmonary Medicine
- Pharmaceutical Technology
- Drug Delivery Systems
Background:
- Inhaled medicines are vital for managing respiratory diseases like asthma, COPD, and cystic fibrosis.
- Inhalation technology offers advantages including rapid action, enhanced bioavailability, and reduced side effects.
- Current research focuses on delivery, particle engineering, devices, and digital health, alongside extending drug action duration.
Purpose of the Study:
- To review advancements in long-acting inhaled medicines (LAIM).
- To explore pharmaceutical technologies and strategies for developing LAIM.
- To discuss emerging long-acting inhaled modalities and future development challenges.
Main Methods:
- Literature review of scientific publications on inhaled medicines and LAIM.
- Analysis of pharmaceutical technologies and strategies for prolonging drug action.
- Examination of emerging inhaled modalities and their therapeutic potential.
Main Results:
- LAIM enhance patient compliance by reducing dosing frequency.
- LAIM improve the effectiveness and convenience of inhaled therapies.
- New pharmaceutical strategies are being developed to create effective LAIM.
Conclusions:
- LAIM represent a significant advancement in respiratory disease management.
- Continued innovation in pharmaceutical technologies is crucial for future LAIM development.
- Addressing challenges in LAIM development will expand treatment options for various diseases.
Related Concept Videos
Inhaled Medications
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...

